Bank of America ( BAC) upgraded at Standpoint. BAC was upgraded from Hold to Accumulate. Stock looks attractively valued following the recent pullback, trading at just 1.15 tangible book value.

First Solar ( FSLR) upgraded at UBS from Neutral to Buy. $150 price target. Estimates also boosted, given higher industry growth rates.

Genuine Parts ( GPC) downgraded at Goldman from Buy to Neutral. Valuation call, based on a $48 price target.

Itron ( ITRI) rated new Outperform at Credit Suisse. ITRI was initiated with an Outperform rating, Credit Suisse said. $70 price target. Company operates in multiple growth areas.

Lowe's ( LOW) upgraded at Goldman. LOW was upgraded from Neutral to Buy, Goldman Sachs said. $24 price target. Margins are finally starting to recover.

Opex Text ( OTEX) upgraded at Morgan Keegan. OTEX was upgraded from Market Perform to Outperform, Morgan Keegan said. $53 price target. Potential for margin expansion and new tax structure should help the company. Estimates also boosted.

United Stationers ( USTR) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $57 price target. Company is growing sales faster than its peers.


Cabot Oil & Gas ( COG) estimates increased at Keybanc. COG estimates were raised through 2011. Continue to see growth potential in the Marcellus shale, despite lower natural gas prices. Buy rating and $48 price target.

Denbury Resources ( DNR) numbers upped at Credit Suisse. DNR estimates were boosted through 2012, Credit Suisse said. Company's production growth should accelerate in the coming quarters. Neutral rating and new $22 price target.

Exelon ( EXC) estimates, target raised at Citigroup. Shares of EXC now seen reaching $39, according to Citigroup. Estimates also increased, given a better regulatory outlook. Hold rating.

Foot Locker ( FL) estimates lowered at Sterne Agee. FL estimates were cut through 2011, Sterne Agee said. Margins could decline from peak levels. Neutral rating.

Hormel Foods ( HRL) numbers boosted at Credit Suisse. Shares of HRL now seen reaching $46. Estimates also upped, given the company's higher realized margins. Neutral rating.

KAR Auction ( KAR) target reduced at Goldman. Shares of KAR now seen reaching $15, according to Goldman Sachs. Estimates also cut, given lower expected auction volumes. Neutral rating.

Lorillard ( LO) estimates raised at Credit Suisse. LO estimates were increased through 2012. Buyback program should add to earnings. Neutral rating and $82 price target.

Microchip Technology ( MCHP) numbers increased at Citigroup. MCHP estimates were raised through 2011, Citigroup said. Business has fully recovered from the downturn. Buy rating and new $36 price target.

Monsanto ( MON) estimates, target raised at Goldman. Shares of MON now seen reaching $73. Estimates also increased, Company received approval for Roundup soybean product in Brazil. Buy rating.

Nordson ( NDSN) estimates upped at BMO through 2012, BMO Capital Markets said. Company is seeing better sales and margins. Outperform rating and $85 price target.

Nextera Energy ( NEE) numbers raised at Oppenheimer. Shares of NEE now seen reaching $58, according to Oppenheimer. Estimates also increased, given higher rates in Floria. Outperform rating.

Nextera Energy ( NEE) numbers boosted at BofA/Merrill. Shares of NEE now seen reaching $60. Last week's rate settlement will add to earnings. Buy rating.

JM Smucker ( SJM) estimates upped, target cut at Goldman. SJM estimates were boosted through 2013, Goldman Sachs said. On the other hand, the target was lowered to $69, given the declining market multiple. Neutral rating.

United Natural Foods ( UNFI) target upped at FBR to $38. Company should deliver better near-term sales growth.

VCA Antech ( WOOF) estimates increased at Kaufman through 2011, Kaufman Bros. said. Company received more attractive financing terms. Hold rating.

Williams-Sonoma ( WSM) estimates upped, target cut at Citigroup. Shares of WSM now seen reaching $32, according to Citigroup. On the other hand, estimates were raised, to match the company's new guidance. Hold rating.
This article was written by a staff member of TheStreet.